Shi Shi

Fudan University — China

Immunology and Microbiology · Life Sciences

16h-index1.2kcitations603works0.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(40), Liver Disease Diagnosis and Treatment(31), Monoclonal and Polyclonal Antibodies Research(28), Hepatitis B Virus Studies(24), Hepatitis C virus research(18)

Publications603 total

Dichoptic Visual Search at Varied Fellow Eye Contrasts and Visual Function Deficits in Amblyopia
Investigative Ophthalmology & Visual Science·2025Open Access
Supplementary Figure S2 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S5 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S6 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S9 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Si-ITGA6-Loaded Liposomes Inhibit Capsule Fibrosis via the FAK/PI3K/Akt Signaling Pathway in Adhesive Capsulitis of Shoulder
International Journal of Nanomedicine·2025· 2 citedOpen Access
Supplementary Tables S1-S10 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Data from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S10 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S7 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S4 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S8 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S6 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S3 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S2 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Table 1 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Table 2 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S5 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S10 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
Supplementary Figure S8 from 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
2025Open Access
page 1 of 31Next →

Frequent Co-authors

Zhang(9), Wang(7), Zhang(6), ‡ Li(6), Li(5), LU LU(5), Liu(5), Huang(4), Zhao(4), Wang(4), Lei Lei(4), Liu(4), Cheng(4), Guo(4), Yi ̆(4), Wu Wu(4), Yan(4), Wei Nie(4), Xiangyang Ye(4), Dong(4)